Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Jennens

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Healthcare (Basel, Switzerland)|July 19, 2016
Malignant MelanomaEshini Perera, Neiraja Gnaneswaran, Ross Jennens, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2020
Response to letter commenting on: Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancerEvangeline Samuel, Cherie Chiang, Ross Jennens, et al.
Journal of Oncology Practice|September 22, 2010
Chemotherapy treatments for metastatic colorectal cancer: is evidence-based medicine in practice?Kathryn M Field, Suzanne Kosmider, Michael Jefford, et al.
Journal of Oncology Practice|September 22, 2010
Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide surveyKathryn M Field, Suzanne Kosmider, Michael Jefford, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 17, 2005
Phase II study of two-weekly temozolomide in patients with high-grade gliomasShirley Wong, Mark A Rosenthal, Anthony Dowling, et al.
Translational Lung Cancer Research|July 23, 2021
A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancerZarique Z Akanda, Paul J Neeson, Thomas John, et al.
Chemotherapy|December 9, 2008
A pilot human evaluation of a formulation of irinotecan and hyaluronic acid in 5-fluorouracil-refractory metastatic colorectal cancer patientsPeter Gibbs, Tracey J Brown, Raymond Ng, et al.
Cancer Research Communications|August 23, 2023
Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma MultiformeJason D Lickliter, Jeremy Ruben, Ganessan Kichenadasse, et al.
Internal Medicine Journal|May 26, 2017
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinomaLavinia Tan, Marliese Alexander, Ann Officer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2022
Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registryJordan Santucci, Mark Tacey, Benjamin Thomson, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Healthcare (Basel, Switzerland)|July 19, 2016
Malignant MelanomaEshini Perera, Neiraja Gnaneswaran, Ross Jennens, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2020
Response to letter commenting on: Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancerEvangeline Samuel, Cherie Chiang, Ross Jennens, et al.
Journal of Oncology Practice|September 22, 2010
Chemotherapy treatments for metastatic colorectal cancer: is evidence-based medicine in practice?Kathryn M Field, Suzanne Kosmider, Michael Jefford, et al.
Journal of Oncology Practice|September 22, 2010
Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide surveyKathryn M Field, Suzanne Kosmider, Michael Jefford, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 17, 2005
Phase II study of two-weekly temozolomide in patients with high-grade gliomasShirley Wong, Mark A Rosenthal, Anthony Dowling, et al.
Translational Lung Cancer Research|July 23, 2021
A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancerZarique Z Akanda, Paul J Neeson, Thomas John, et al.
Chemotherapy|December 9, 2008
A pilot human evaluation of a formulation of irinotecan and hyaluronic acid in 5-fluorouracil-refractory metastatic colorectal cancer patientsPeter Gibbs, Tracey J Brown, Raymond Ng, et al.
Cancer Research Communications|August 23, 2023
Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma MultiformeJason D Lickliter, Jeremy Ruben, Ganessan Kichenadasse, et al.
Internal Medicine Journal|May 26, 2017
Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinomaLavinia Tan, Marliese Alexander, Ann Officer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2022
Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registryJordan Santucci, Mark Tacey, Benjamin Thomson, et al.
Pageof 2